Myung Cho1, Xiaodong Wu1,2, Hossein Dadkhah3, Jirong Yi1, Ryan T Flynn2, Yusung Kim2, Weiyu Xu1. 1. Department of Electrical and Computer Engineering, University of Iowa, 4016 Seamans Center, Iowa City, IA, 52242, USA. 2. Department of Radiation Oncology, University of Iowa, 200 Hawkins Drive, Iowa City, IA, 52242, USA. 3. Department of Biomedical Engineering, University of Iowa, 1402 Seamans Center, Iowa City, IA, 52242, USA.
Abstract
PURPOSE: To provide a fast computational method, based on the proximal graph solver (POGS) - A convex optimization solver using the alternating direction method of multipliers (ADMM), for calculating an optimal treatment plan in rotating shield brachytherapy (RSBT). RSBT treatment planning has more degrees of freedom than conventional high-dose-rate brachytherapy due to the addition of emission direction, and this necessitates a fast optimization technique to enable clinical usage. METHODS: The multi-helix RSBT (H-RSBT) delivery technique was investigated for five representative cervical cancer patients. Treatment plans were generated for all patients using the POGS method and the commercially available solver IBM ILOG CPLEX. The rectum, bladder, sigmoid colon, high-risk clinical target volume (HR-CTV), and HR-CTV boundary were the structures included in our optimization, which applied an asymmetric dose-volume optimization with smoothness control. Dose calculation resolution was 1 × 1 × 3 mm3 for all cases. The H-RSBT applicator had 6 helices, with 33.3 mm of translation along the applicator per helical rotation and 1.7 mm spacing between dwell positions, yielding 17.5° emission angle spacing per 5 mm along the applicator. RESULTS: For each patient, HR-CTV D90 , HR-CTV D100 , rectum D2cc , sigmoid D2cc , and bladder D2cc matched within 1% for CPLEX and POGS methods. Also, similar EQD2 values between CPLEX and POGS methods were obtained. POGS was around 18 times faster than CPLEX. For all patients, total optimization times were 32.1-65.4 s for CPLEX and 2.1-3.9 s for POGS. CONCLUSIONS: POGS reduced treatment plan optimization time approximately 18 times for RSBT with similar HR-CTV D90 , organ at risk (OAR) D2cc values, and EQD2 values compared to CPLEX, which is significant progress toward clinical translation of RSBT.
PURPOSE: To provide a fast computational method, based on the proximal graph solver (POGS) - A convex optimization solver using the alternating direction method of multipliers (ADMM), for calculating an optimal treatment plan in rotating shield brachytherapy (RSBT). RSBT treatment planning has more degrees of freedom than conventional high-dose-rate brachytherapy due to the addition of emission direction, and this necessitates a fast optimization technique to enable clinical usage. METHODS: The multi-helix RSBT (H-RSBT) delivery technique was investigated for five representative cervical cancerpatients. Treatment plans were generated for all patients using the POGS method and the commercially available solver IBM ILOG CPLEX. The rectum, bladder, sigmoid colon, high-risk clinical target volume (HR-CTV), and HR-CTV boundary were the structures included in our optimization, which applied an asymmetric dose-volume optimization with smoothness control. Dose calculation resolution was 1 × 1 × 3 mm3 for all cases. The H-RSBT applicator had 6 helices, with 33.3 mm of translation along the applicator per helical rotation and 1.7 mm spacing between dwell positions, yielding 17.5° emission angle spacing per 5 mm along the applicator. RESULTS: For each patient, HR-CTV D90 , HR-CTV D100 , rectum D2cc , sigmoid D2cc , and bladder D2cc matched within 1% for CPLEX and POGS methods. Also, similar EQD2 values between CPLEX and POGS methods were obtained. POGS was around 18 times faster than CPLEX. For all patients, total optimization times were 32.1-65.4 s for CPLEX and 2.1-3.9 s for POGS. CONCLUSIONS: POGS reduced treatment plan optimization time approximately 18 times for RSBT with similar HR-CTV D90 , organ at risk (OAR) D2cc values, and EQD2 values compared to CPLEX, which is significant progress toward clinical translation of RSBT.
Authors: Richard Pötter; Christine Haie-Meder; Erik Van Limbergen; Isabelle Barillot; Marisol De Brabandere; Johannes Dimopoulos; Isabelle Dumas; Beth Erickson; Stefan Lang; An Nulens; Peter Petrow; Jason Rownd; Christian Kirisits Journal: Radiother Oncol Date: 2006-01-05 Impact factor: 6.280
Authors: Christian Kirisits; Stefan Lang; Johannes Dimopoulos; Daniel Berger; Dietmar Georg; Richard Pötter Journal: Int J Radiat Oncol Biol Phys Date: 2006-06-01 Impact factor: 7.038
Authors: Kelly D Dewitt; I Chow Joe Hsu; Joycelyn Speight; Vivian K Weinberg; Etienne Lessard; Jean Pouliot Journal: Int J Radiat Oncol Biol Phys Date: 2005-11-15 Impact factor: 7.038
Authors: Richard Pötter; Johannes Dimopoulos; Petra Georg; Stefan Lang; Claudia Waldhäusl; Natascha Wachter-Gerstner; Hajo Weitmann; Alexander Reinthaller; Tomas Hendrik Knocke; Stefan Wachter; Christian Kirisits Journal: Radiother Oncol Date: 2007-05 Impact factor: 6.280